TABLE 2.
Summary of blood pressure thresholds and targets for persons with stroke
| Context | BP threshold for initiating pharmacotherapy | Blood pressure targets | Preferred agents |
|---|---|---|---|
| In‐hospital Mgt | Refer to Neurologist for specialist management | Intravenous titratable anti‐hypertensives | |
| Acute Ischemic Stroke (AIS), eligible for IV thrombolysis but not for mechanical thrombectomy | >185/110 mm Hg |
<185/110 mm Hg prior to thrombolysis and during infusion; 180/105 mm Hg in the next 24 h |
Nicardipine 1–5 mg/h IV, titrate up by 2.5 mg/h every 5–15 min, with maximum of 15 mg/h. If available: alternative of labetalol 10 mg IV over 1–2 min followed by continuous IV infusion of 2–8 mg/min. |
| AIS, not eligible for IV thrombolysis or mechanical thrombectomy |
Severe hypertension: SBP of > 220 mm Hg DBP of > 120 mm Hg |
If with severe hypertension, reduce the BP by 15% during the first 24 h after the onset of stroke | IV Nicardipine as indicated above |
| Intracerebral Hemorrhage (ICH) | SBP ≥180 mm Hg |
<180 mm Hg Careful SBP lowering, avoiding reductions ≥60 mm Hg in 1 h Do not lower the BP acutely to <140 mm Hg |
First choice: IV Nicardipine Second choice: IV labetalol |
|
Secondary prevention Adults with history of stroke |
140/90 mm Hg |
≤ 130/80 mm Hg |
First line: RAS blockers (ACE‐Inh, ARB), CCBs and thiazide diuretics |